Style
Deep ValueTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Crispr Therapeutics AG(CRSP) | 3,220,627 | $175.7M | 29.17% |
| 2 | Wave Life Sciences LTD(WVE) | 18,245,691 | $106.0M | 17.60% |
| 3 | VIR Biotechnology Inc(VIR) | 8,550,954 | $87.1M | 14.47% |
| 4 | Biontech SE(BNTX) | 889,824 | $82.8M | 13.75% |
| 5 | Ideaya Biosciences Inc(IDYA) | 1,333,333 | $49.7M | 8.25% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 52.35% | 53.23% | +0.88% |
| Unclassified | 47.65% | 46.77% | -0.88% |
Quarter-over-quarter weight changes by market cap
Quarter-over-quarter position changes
| Cytokinetics Inc(CYTK) |
| 340,434 |
| $29.0M |
| 4.82% |
| 7 | Lyell Immunopharma Inc(LYEL) | 1,512,659 | $21.3M | 3.53% |
| 8 | Spero Therapeutics Inc(SPRO) | 9,190,606 | $20.3M | 3.37% |
| 9 | Nkarta Inc(NKTX) | 3,150,732 | $8.9M | 1.48% |
| 10 | Fulcrum Therapeutics Inc(FULC) | 1,785,714 | $6.5M | 1.09% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Unclassified | 47.65% | 46.77% | -0.88% |
| Small Cap | 21.7% | 20.7% | -1% |
| Large Cap | 13.2% | 13.75% | +0.55% |
| Mid Cap | 11.16% | 13.07% | +1.91% |
| Micro Cap | 6.29% | 5.71% | -0.58% |